Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 17 (RPSAP17) is a processed pseudogene related to the gene encoding ribosomal protein SA (RPSA)[3][1]. Pseudogenes are non-functional segments of DNA that resemble functional genes but typically lack the capacity to encode proteins or exert direct biological effects. RPSAP17 does not encode a functional protein and is not known to play a direct biological or disease role. It is distinct from the parent RPSA gene, which encodes a multifunctional ribosomal protein and laminin receptor with involvement in metastasis and cancer progression[9]. RPSAP17 is not considered a therapeutic target, gene marker, or receptor, and has no established link to drug interactions or disease pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 17 (RPSAP17).